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Abstract: In spite of lacking evidence for effects on cancer progression itself, an 
increasing number of cancer patients use various types of complementary and alternative 
medicine (CAM). There is disagreement between CAM practitioners, researchers and 
clinical oncologists, as to how evidence concerning effects of CAM can and should be 
produced, and how the existing evidence should be interpreted. This represents a 
considerable challenge for oncologists; both in terms of patient needs for an informed 
dialogue regarding CAM, and because some types of CAM may interact with standard 
treatments. There is a need for insight into which kinds of CAM may work, for whom they 
work, what the possible effects and side-effects are, and in what ways such effects may 
come about. The present article presents a framework for evaluating effects of CAM by 
suggesting a taxonomy of different levels of evidence related to different types of research 
questions and discussing the relevance of different research methodologies for different 
types of effects. 
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1. Introduction 
Complementary and alternative medicine (CAM) represents a considerable challenge for 
oncologists, both in terms of patient needs for an informed dialogue regarding CAM, because some 
types of CAM may interact with standard treatments [1], and because excessive use of some types  
of CAM, e.g., certain herbal remedies and vitamin supplements, may have detrimental health  
effects [2,3].  
A European survey from 2005 revealed that 36% of cancer patients supplement their conventional 
treatment with various types of CAM, with usage ranging from 15 to 73% in the 14 countries included 
in the study [4]. Economically, CAM represents a considerable industry with an estimated $34 billion 
out-of-pocket expenditure in the U.S., but with the majority of CAM types still remaining to be 
evaluated [5,6]. CAM is thus part of the clinical reality for many cancer patients today, and for this 
reason alone, research in CAM and CAM use is highly relevant, both from a societal perspective and 
to clinical practice.  
CAM is a highly diverse category of treatments with large between-country differences in types and 
usage, but is commonly defined as ―diagnosis, treatment, and/or prevention which complements 
mainstream medicine by contributing to a common whole, by satisfying a demand not met by 
orthodoxy or by diversifying the conceptual frameworks of medicine‖ [7]. Although countries differ in 
their traditions for the naming of these forms of medicine, and although variations in the use of the 
terms alternative, complementary, and integrative medicine often relate to different positions on 
conventional treatment, in the following we use CAM as a broad generic term covering therapies that 
are generally not part of conventional oncology treatment. 
Although it is highly debated both how evidence concerning effects of CAM can and should be 
produced, and how the existing evidence should be interpreted, the majority of CAM research 
conducted so far has focused on documenting possible effects on physical symptoms and/or 
psychological well-being. The available results are generally inconsistent, and authors of systematic 
reviews repeatedly argue that the available research is based on samples that are too small and on 
research having methodological flaws, and that decisive conclusions therefore cannot be  
supported [8-11]. The methodological issues may to some degree be associated with the ongoing 
disagreement among researchers as to what the appropriate methodology for CAM research should be. 
While conventional medical researchers generally agree that CAM should be subjected to the same 
rigorous standards applied to studies of conventional therapies, e.g., randomized and placebo 
controlled trials, CAM practitioners often raise objections to the relevance of conventional scientific 
methodologies, claiming that these methods do not capture the true effects of CAM. To many 
practitioners and users of CAM, the subjective experience and report of patients confirming that they 
experience reduction of symptoms, increased well-being, or simply that they subjectively feel the 
treatment works, are the most important criteria of effect. 
Evidence of effect is an inevitable requirement if a therapeutic method is to be integrated in 
conventional health care. It is therefore relevant to reconsider how to best investigate effects of CAM. 
There is a need for insight into which kinds of CAM may work, for whom they work, what the effects 
are, and in what ways the effects come about. In this paper, we propose a framework for evaluating 
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and discussing effects of CAM by suggesting a taxonomy of effects, discussing the relevance of 
different research methodologies for different types of effect, and pointing to needs for future research. 
2. A Framework for Evaluating Effects 
When looking at the available clinical research on CAM, it is obvious that the qualities usually 
adhered to in clinical trials are only partially met. Usually, studies of CAM for cancer are rather small, 
and a number of aspects such as blinding and randomization are often lacking, although some 
improvement has been seen within the last decade. For example, a brief overview of clinical studies of 
massage administered to cancer patients reveals that the six identified studies published from  
1985–1999 included an average of 36 patients and only four studies had control groups (cross-over 
design, massage without essential oils, or rest). During the period 2000–2007, a further 18 studies were 
published, with a mean of 65 patients and all with control groups (standard care, conversation, or 
placebo treatment). In 2008, three new randomized controlled trial (RCT)s investigating massage for 
cancer were published with a mean of 214 patients in each study and randomization of patients to 
massage or control, but still lacking information on whether patients, practitioners or data-processing 
personnel were blinded [12]. No multi-center studies or meta-analyses have been identified, and one 
recent review states that it was not possible to conduct a meta-analysis of studies of massage in the 
care for patients with cancer due to the wide range of massage techniques, therapeutic settings, and 
patient profiles [13]. As demonstrated by this brief sketch, while the number of studies on massage for 
cancer patients per year as well as the number of patients included in the studies is slowly increasing, 
as is concurrency with standard demands of RCTs, there is still a way to go before research on 
massage to cancer patients resembles ongoing research of conventional treatment effects. The same 
appears to be the case for many other types of CAM.  
The size of a study sample, inclusion of control groups, and blinding are formal design issues. 
Another issue concerns what research questions a study actually addresses. In recent years, it has been 
a requirement in oncology research to test a new therapy not only for its ability to cure the cancer, but 
also to assess its possible side effects and the implications for the quality of patients‘ lives. Addressing 
all of these issues in clinical trials provides practitioners and patients with an improved basis for 
informed choice of treatment. One could argue that if oncologists should be able to discuss the use of 
CAM with their patients, the same issues should preferably be covered in CAM research. However, the 
discussions may need to be framed differently, as no form of CAM so far has been shown to influence 
the prognosis of cancer in large and well conducted RCTs. Patients, nevertheless, often wish to discuss 
their use of CAM with the oncologist, and oncologists need a suitable framework for discussing the 
available evidence or lack of evidence with respect to CAM. 
We suggest that when exploring the level of evidence for the effects of a treatment, a full 
investigation must include information on (I) subjective, self-reported effects, e.g., effects on nausea, 
pain, or general well-being; (II) objective, physiological effects; e.g., changes in tumor size or relevant 
immune and endocrine parameters, and (III) whether the mechanisms of effect correspond to the 
theory of the particular treatment, e.g., evidence that water molecules can retain the ―memory‖ of a 
given substance as proposed in homeopathy. These three elements cover different, complementary 
aspects of the question concerning therapeutic effect, and one can argue that all three should be well 
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documented before the efficacy of a given treatment can be considered to be well established. As an 
aid to more productive discussions on effects of CAM, we propose a clearer distinction between 
different explanatory levels of evidence (Table 1). 
Table 1. Explanatory levels of evidence. 
Explanatory 
Level of 
Evidence 
Documented 
Subjective Effect 
 
I 
Documented 
Physiological Effect 
 
II 
Documented Mechanisms 
Corresponding to the 
Theory of the Treatment 
III 
A 
1 
+ + + 
B 
2 
+ + - 
C 
3 
+ + - 
D 
4 
+ - - 
E 
5 
+ - - 
F 
6 
- - - 
1 Evidence of specific effects beyond placebo and evidence supporting the proposed theory of 
treatment.  
2 Evidence beyond placebo of effects on specific symptoms.  
3 Evidence of effects on specific symptoms, but no difference from placebo, indicating non-specific 
mechanisms.  
4 Evidence of self-reported effects on specific symptoms, but no documented physiological effects.  
5 Evidence of effects on self-reported general well-being, but no documented physiological effects.  
6 No evidence of any self-reported or physiological effects. 
At evidence level A, we would find studies that are able to establish and confirm all three aspects of 
effects of the tested therapy. Evidence for the effects of a treatment at level A requires evidence of 
significant improvement of specific patient-reported symptoms as well as improvements in specific 
physiological symptoms compared to placebo, or if an effective standard treatment is available, 
treatment as usual. Furthermore, level A requires that mediating mechanisms that correspond to the 
mechanisms proposed by the theory of the treatment in question have been tested and verified.  
At level B, we find studies that have provided evidence of improvement of specific patient-reported 
symptoms as well as improvement of specific, relevant physiological processes, when compared to 
treatment as usual or placebo, but no evidence of, or perhaps even evidence contrary to, the 
mechanisms proposed by the theory of the treatment.  
Evidence level C refers to treatments for which there is evidence of significant improvement of 
specific subjective symptoms as well as relevant physiological measures, but where the effects do not 
differ from those obtained by placebo and therefore may be attributed to ―non-specific‖ psycho-
physiological mechanisms.  
At evidence level D and E, we find studies with results that indicate self-reported effects, but where 
it has neither been possible to document effects on any physiological symptoms nor to document the 
mechanisms of effect. In the category D, the treatment outcomes are specific (e.g., fatigue, nausea, 
anxiety), while they are general or non-specific in category E (e.g., general well-being). Finally, level F 
refers to the situation where it has neither been possible to document any significant effect on self-reported 
well-being nor on specific symptoms, and for which there are no documented mechanisms of effects. 
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We believe that the taxonomy outlined in Table 1 could be useful in classifying the available 
evidence for various therapeutic interventions. Today, biomedical cancer treatments are tested not only 
for their physiological effects but also with respect to subjective effects (e.g., side effects and other 
aspects of quality-of-life), and the working mechanisms are generally well known. While a substantial 
number of conventional cancer therapies in use today are well-documented at evidence level A, we 
have been unable to identify any CAM modality for which there is the same level of documentation. 
While this may be the reason why they are categorized as complementary and alternative, it does not 
necessarily mean that they are of no value. There may thus be treatments that have no documented 
biological effects on cancer, and for which we do not know the working mechanisms, but nevertheless 
may help cancer patients feel better and improve their quality-of-life. The issue is not simply a 
question of whether there is evidence or not, but of what type of evidence. 
3. Research Questions and Methodological Challenges 
The overall framework presented in Table 1 can be further elaborated into specific types of research 
questions and their corresponding methodologies. We suggest that research questions and hypotheses 
can be structured according to at least six domains of questions relating to the three main aspects of 
evidence proposed in Table 1. We also suggest that the research questions asked may require different 
methodologies to be answered in a satisfactory manner, given that various methods have their 
strengths and weaknesses within each of the different domains. The research questions that can be 
asked, relevant research designs, and examples of methodological challenges within each of these 
domains are summarized in Table 2. As a more detailed illustration of the model, we will examine a 
few examples of CAM research at each level. 
3.1. Testing Theories of Mediating Mechanisms 
To evaluate the evidence at level A, we need to ask the question whether a given effect of a specific 
therapy is produced by the mechanisms proposed by the theory associated with the therapy in question.  
One illustrative example could be so-called spiritual- or energy healing. While there are several 
types of energy healing, proponents generally attribute effects of these types of treatment to various 
sources, e.g., ―spirits‖, God, ―universal forces‖, or ―biological healing energies‖ residing in the healer 
or receiver of healing. Proponents of energy healing generally agree that healing can be performed ―at 
a distance‖ without conscious awareness on the part of the recipient, and the recipient can be any 
living being, i.e., person, animal, plant or other living system [14]. While the suggested sources, e.g., 
―spirits‖, usually are beyond what can be tested scientifically, the theory of energy healing consists of 
at least two aspects that while being controversial from a conventional scientific viewpoint may be 
subjected to scientific testing: 1) that healing can influence any living system, including individual 
cells, and 2) that the healing can be performed ―at a distance‖ without conscious awareness of the 
recipient. However, only few published studies have directly attempted to address these questions. 
Some researchers have investigated whether energy healing can inhibit the viability and growth of 
cancer cells in vitro, some reporting positive results [15,16], while others have been unable to replicate 
these findings [17]. If well-controlled future studies are able to confirm that cancer cells in vitro can 
indeed be influenced by spiritual healing, this could be taken as supporting both aspects of the theory. 
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Table 2. Relevant research questions, designs and methodological challenges. 
Research 
Domain 
Explanatory 
Level of 
Evidence 
Research Question Relevant Designs 
Examples of 
Methodological 
Challenges 
I.  
Theoretical  
 
A Does the therapy have 
subjective and 
physiological effects that 
can be explained by the 
mechanisms proposed by 
its theory 
 
Controlled experiments 
investigating the 
proposed mediating 
mechanisms 
 
Developing research 
designs capable of 
testing the theory on its 
own premises, while 
controlling for possible 
alternative explanations. 
 
II.  
Specific 
physiological  
 
B Does the therapy have 
documented specific 
physiological effects 
beyond those than can be 
attributed to expectancy 
and other non-specific 
mechanisms (placebo)? 
 
Double-blinded, 
randomized, placebo-
controlled trials 
 
Choosing relevant and 
valid physiological 
measures, ensuring 
effective blinding of 
conditions, controlling 
for natural improvement 
 
III.  
Non-specific 
physiological  
 
C Does the therapy have 
documented 
physiological effects, 
regardless of the 
mechanisms involved? 
 
Randomized, controlled 
trials 
 
Choosing relevant 
health-related 
physiological measures 
and controlling for 
natural improvement 
 
IV.  
Specific self-
reported  
 
D Does the therapy have 
documented specific self-
reported effects beyond 
those than can be 
attributed to expectancy 
and other non-specific 
mechanisms (placebo)? 
 
Double-blinded, 
randomized, placebo-
controlled trials 
 
Choosing valid, specific 
self-report measures. 
Controlling for non-
specific factors and 
natural improvement 
 
V. 
Nonspecific 
self-reported 
 
E Does the therapy have 
non-specific effects on 
various aspects of well-
being? 
  
Randomized, controlled 
trials 
 
Choosing relevant and 
valid self-report 
measures, controlling 
for non-specific factors 
and natural 
improvement 
 
VI. Individual 
meaning 
 
E What are the patients  ´
experiences of the 
therapy and its effects? 
 
Studies of patients  ´
health-beliefs, 
expectations, and 
perceptions of the 
therapy and its effects. 
 
Adequate study size, 
transparency and 
validity in research 
methodology, 
comparisons with non-
users. 
Cancers 2011, 3                
 
 
779 
Intercessory prayer, i.e., having a group of individuals pray for a group of patients without the 
patients being aware that they are being prayed for, is another example of spiritual- or energy healing. 
A small but growing number of randomized clinical trials have investigated whether this form of 
intervention may have a positive influence on patients‘ health status [18]. Most studies have focused 
on other diseases than cancer, e.g., coronary heart disease, and while there are positive reports [19], the 
findings have generally been negative [20]. The methodological quality and the interpretability of the 
available results is limited, but, again, if results of future well-controlled studies consistently confirm 
effects of intercessory prayer that cannot be explained by other factors, this could be taken as 
supporting at least the theoretical claim that energy healing works at a distance.  
Several other widely used types of CAM involve theories of working mechanisms that are 
controversial within conventional science. One example is acupuncture, which is often used by cancer 
patients to reduce treatment-induced side effects, e.g., nausea. While there are variations, most 
acupuncture treatments are based on ancient Chinese theories claiming that the health of an organism 
depends on the flow of the ―life force‖ of Qi, and that disease stems from imbalances and blocking of 
the flow of Qi through meridians in the body [21]. The traditional Chinese theory of acupuncture 
implies that bodily balance can be restored by stimulating specific meridian points that are believed to 
correspond to specific clusters of organs, sentiments, and qualities, e.g., temperatures of hot or cold [22]. 
There have been several attempts to document the existence of the meridians. Photographic images or 
measurements of electric currents supposedly revealing meridians in the body have been provided as 
proof of their existence, but the validity of these techniques has been questioned by other researchers, 
and the existence of meridians is still undocumented scientifically [23]. From the theoretical 
viewpoint, a fundamental question concerning the validity of the traditional theories of acupuncture is 
whether acupuncture needles must be inserted in specific points to have an effect. While adherents of 
the theory insist that individual specific points have identifiable and reproducible clinical effects, some 
practitioners of modern (Western) medical acupuncture find that it makes little difference exactly 
where the needles are inserted [24]. This conclusion is supported by results from several large  
multi-center trials showing that while acupuncture may be more effective than no treatment, it is 
generally not better than sham acupuncture in non-specific points [25-27]. In addition, such findings 
do not rule out the possibility that the effects of acupuncture are due to psychological mechanisms, 
e.g., ―placebo-effects‖ resulting from positive expectation on the part of the patient and/or the 
practitioner. Various forms of ―placebo-acupuncture‖ have been suggested, including placebo-needles 
that are claimed to enable double-blinding but do not penetrate the skin as well as other forms of so-
called minimal acupuncture using blunt needles or superficial needling [28], although there is still 
some disagreement concerning the validity of these methods [29]. Other approaches involve using 
brain-imaging techniques to compare results of stimulating specific points to those obtained by sham 
acupuncture. While there have been some reports of point specificity, e.g., increased blood flow in the 
auditory cortex following stimulation of an ear-specific point, others have been unable to replicate 
these findings [30].  
Homeopathy is another form of therapy that has become increasingly popular among cancer 
patients [4], and some cancer patients have even been reported to use homeopathy as an alternative to 
conventional treatment, with increased recurrence and mortality as a result [31]. Like energy healing 
and classical acupuncture, homeopathy is based on theoretical mechanisms that differ markedly from 
Cancers 2011, 3                
 
 
780 
anything known within conventional treatment. The fundamental theorem of homeopathy, ‗similia 
similibus curentur‘ (like cures like), was formulated by the founder of homeopathy, the German medic 
Samuel Hahnemann (1755–1845), and refers to a working principle stating that the symptoms 
provoked by a substance in its natural form will be cured by the same substance highly diluted [32]. 
The production of homeopathy involves repeated dilutions and shaking (probing) of the original 
substances, sometimes to the extent that the chance to find any of the original substance is close to 
null. In theory, the higher the dilution, the stronger the effect. The therapeutic effect has been 
explained to result from a type of ―memory‖ of the original substance retained in the water molecules 
of the dilution [33]. An attempt to test this hypothesis is represented by Jacques Beneviste, who in 
1988 published a controversial paper in Nature reporting effects of highly diluted anti-IgE on 
degranulation of basophil cells. The paper was later withdrawn, when attempts to replicate the findings 
failed [34], and the theory behind homeopathy still remains invalidated [35]. 
As demonstrated above, the validity of theories of working principles of many complementary 
therapies have not been supported by research, and research designs specifically tailored to test the 
theories in question are needed. To provide evidence at level A for a given CAM, there is a need for 
developing designs that both meet conventional scientific requirements and are able to test the theory 
of the CAM in question on ―its own terms‖. While this may be technically possible in some instances, 
other CAM theories may be unsuited for scientific testing, i.e., by referring to immeasurable entities.  
3.2. Specific and General Physiological Effects 
Evidence at levels B and C are concerned with physiological effects. While it may not be possible 
to find evidence for the theory of a therapy or even to test it at the theoretical level, e.g., the failure to 
validate the theory of point specificity in acupuncture, this does not exclude the possibility that the 
therapy has identifiable effects at the specific physiological level. At the level of physiological effects, 
the key question is whether some forms of CAM are able to produce relevant physiological effects, 
e.g., reduce cancer growth, improve relevant immune measures, reduce observable side-effects, or 
prolong survival. 
It has been demonstrated in several studies that the use of complementary medical products is by far 
the most popular supplement to conventional cancer treatment among cancer patients. Shark cartilage, 
for instance, has for some decades been popular among cancer patients. The basis for this popularity 
has been the claim that sharks rarely get cancer because of the high proportion of cartilage in their 
bodies, and some laboratory research has suggested the existence of antiangiogenic and anti-tumoral 
compounds in shark cartilage [36]. However, sharks do in fact develop cancer [37], and the results of 
randomized clinical trials with cancer patients have been disappointing [38]. Another example is 
mistletoe extract, which is often used by cancer patients and is claimed to improve survival. However, 
a recent meta-analysis of the available randomized clinical trials has revealed no effect on survival [39]. 
When testing potential specific physiological effects of a CAM, e.g., on tumor growth, survival or 
side-effects, disregarding whether the treatment works according to its own theoretical claims or not, 
the golden standard of clinical research, i.e., the RCT, remains the ideal methodological choice. When 
testing herbal medicines or other non-conventional medicines, e.g., shark cartilage, mistletoe or 
antioxidants, it should be possible to evaluate the evidence at level B. Here RCTs do not pose any 
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serious methodological problems, as the proposed active substance usually can be tested in a double-
blinded manner against an inactive substance—usually in addition to treatment-as-usual. It should be 
noted, however, that research in other areas suggests that since active substances are often associated 
with side-effects that are not found in the usual inactive placebo-treatments, this may threaten the 
efficacy of a blinding procedure, thereby increasing the risk of type-1 error [40].  
As suggested above, other unconventional therapies pose more serious methodological challenges. 
The difficulties in providing acceptably valid double-blinded conditions for acupuncture remains a 
serious hindrance for the testing of whether this type of CAM has any relevant clinical effects beyond 
placebo, i.e., at evidence level B. The same applies to other types of CAM, such as Qigong, a Chinese 
type of meditative exercise. Although there are reports of improved survival and reduced tumor size 
among cancer patients practicing Qigong, the methodological quality of the available studies is 
limited, and so far, no double-blinded clinical trials have been conducted [41], and hence claims for 
clinical efficacy can be questioned. Here it should, however, be noted that blinding is also often not 
possible or ethical when testing conventional cancer treatments, e.g., chemo- or radiotherapy, due to 
the nature of these treatments. 
3.3. Self-Reported Effects on Symptoms and Well-Being 
Evidence levels D and E are concerned with self-reported effects. Besides physiological aspects 
observable by a third party, e.g., the size of a tumor, a number of physical consequences of cancer and 
cancer treatment, including nausea, fatigue, and pain, can only be assessed by patient self-report. 
Nausea as a common side effect of chemotherapy and the experience of pain as an adjunct symptom 
connected with cancer, are highly discomforting for cancer patients, and it could therefore be 
worthwhile to look for CAM as a potential remedy for such symptoms and problems. Meta-analyses of 
the available literature indicates, for instance, that acupuncture may reduce nausea after chemotherapy, 
although the mechanisms are still unknown [42]. The research also suggests that acupuncture may 
have analgesic effects, even though such effects can be found for any acupuncture point and not only 
for theoretically specific points [24].  
Questionnaire-based investigations of health-related quality-of-life represent another approach to 
evaluating self-reported effects of CAM, and the literature indicates the possibility of some effects in 
this area. For instance, although mistletoe therapy has not been shown to prolong survival time, there 
is some evidence to suggest that it may provide some improvement of quality-of-life for cancer 
patients [39]. Our data from an ongoing nationwide cohort study of Danish women treated for early 
stage breast cancer [43] indicate that almost 40% of the women had used some type of CAM within  
3–4 months after surgery, and more than 50% had used CAM within the following 12 months. While 
approximately one-third of the CAM users in this cohort were either absolutely or relatively certain 
that their CAM would have a beneficial effect on the disease itself and 39% believed an effect was 
possible, the remaining 27% did not believe that the CAM they was using would have any effect on 
the disease, suggesting that for many patients, cure or prolonged survival may not, as discussed below, 
be the primary reason for use [44].  
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3.4. Treatment as a Meaning-Generating Activity  
As indicated above, although there is no clear evidence of relevant physiological effects, quantitative 
questionnaire-based studies suggest that the use of CAM may be associated with self-reported effects 
on various aspects of quality-of-life of cancer patients. These findings may be complemented by 
studies based on qualitative methodologies, e.g., interviews and participant-observation. A growing 
number of studies have applied qualitative methods to the investigation of patients‘ experience of 
effects of CAM-modalities, and although the number of participants in these studies is usually small, 
they may provide substantial clues as to why cancer patients use CAM, thereby providing explanations 
for the continued use in spite of the lack of hard evidence of effects. The available qualitative studies 
have rarely been concerned with patients with one type of cancer and generally attempt to explore 
cancer patients‘ subjective experiences of living with a malignant disease, and the results indicate that 
CAM may be a tool for adapting to the new life situation of living with cancer.  
In an interview study at a clinic of integrative medicine in Vancouver [45], the stories of 11 
participants suggested that they underwent a transformation process involving learning about 
themselves, of becoming more aware of who they are and how they relate to the world. This new 
understanding about their selves and how they related to others seemed to provide participants with a 
new direction for improving their lives notwithstanding the cancer they suffered. The analysis 
suggested that this process of personal development evolved along a process of four stages: looking to 
options other than conventional treatment; doing ‗inner work‘, i.e., revisions of conceptions of what 
life and illness is all about; witnessing a shift in inner well-being, i.e., a redirection of goals and means 
in life; and seeing the world and oneself through new eyes. Similar aspects associated with the use of 
CAM were found in an interview study comparing breast cancer patients using anthroposophical 
medicine and care with matched breast cancer patients using only conventional medicine [46]. The 
results suggested that the women using anthroposophical medicine, to a greater extent than those using 
only conventional medicine, emphasized the importance of self-reflection and the meaning-of-life. 
Important changes noticed were an appreciation of the beauty of life, experiences of threat, 
introspection into self and meaning of life, and changes in the body. The group that received 
anthroposophical care seemed to be more orientated towards personal growth and meaning of life, 
whereas the matching group was more orientated towards external activities and bodily changes. 
Important issues were the women‘s openness to their own vulnerability, combined with their search for 
emotional expansion and the necessary strength to meet this vulnerability. The study points to the 
guidance towards meaning, purpose in life, and increased quality-of-life as potential implications of 
CAM use. In a third study, Billhult and Dahlberg interviewed eight cancer patients receiving massage 
as an adjunct therapeutic intervention. This study identified five themes of importance to the 
participants: the massage was meaningful because (1) it offered the patient an experience of being 
―special‘‘; (2) contributed to the development of a positive relationship with the staff, (3) supported a 
subjective feeling of being strong, and (4) supported a balance between autonomy and dependence. 
Finally, (5) the massage supported an immediate experience of ―feeling good‘‘ [47].  
That CAM may provide meaningful options for cancer patients is further supported by our research 
of Italian cancer patients suggesting that the use of CAM may provide patients with means to act in a 
meaningful way when facing cancer [48]. In one example, a patient suffering from cancer of the colon 
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with metastases to the liver reported use of several forms of herbal medication. In repeated interviews, 
the patient never mentioned the herbal medicines as curative treatment, as he clearly considered that to 
be taken care of at the hospital. Instead he emphasized the need to stimulate the organs that were 
hampered by the disease, especially since they were important organs for the uptake of nutrients, and 
found it very important to feed the body well when suffering from cancer and undergoing the harsh 
conventional treatments. This man‘s story is typical in the sense that it reflects a distinction between 
curative cancer treatment provided at the hospital, and complementary medicines employed to cope 
with side effects of hospital treatment and to support the functioning of diseased organs. Italian 
patients that used herbal medicine and homeopathy generally expressed this distinction in expectations 
to different forms of medicine, and users of CAM generally reported themselves to be less burdened 
with side-effects of chemotherapy, when comparing themselves to those patients that did not use 
complementary medicines [49].  
The studies using qualitative methods generally include small numbers of informants, and only few 
include control groups, which limits the generalizability of results from each study on its own. Taken 
together, however, all such studies point to subjective experiences of CAM as an important factor in 
the creation of meaning in the midst of the chaotic and frightening experience of a life-threatening 
disease. We cannot know, among other things due to the lack of longitudinal designs and control 
groups, whether the use of CAM is the product of or the reason for the meaning-creating processes 
observed. Although there is no evidence to suggest that CAM may cure cancer or improve  
cancer-related physical outcomes, the limited evidence suggests that CAM use may have the potential 
to be experienced as purposeful by some patients, and may thus help these patients cope with their 
cancer. Further studies with larger, representative samples are needed to explore the generalizability of 
these findings. 
4. Conclusions 
There is no doubt that use of CAM is frequent among cancer patients, and many seek CAM as a 
means to combat the disease. This aim is understandable, considering the seriousness of the disease 
and the limited effectiveness of many conventional cancer treatments. However, in spite of decades of 
research on CAM modalities, the available results have been unable to verify the suggested working 
mechanisms of several widely used types of CAM, and for energy healing, acupuncture, homeopathy, 
and many other forms of CAM, there is no evidence at level A.  
Many patients turn to CAM to find some alternative or supplementary form of cure or  
life-prolonging effect, but while there have been some reports of promising results, none of the 
available systematic reviews, including meta-analyses, have been able to support claims of CAM with 
respect to curing or improving the prognosis of cancer. It is, however, important to note that since 
double-blinding is often difficult or not possible due to the character of many forms of CAM  
(e.g., acupuncture and physical exercises like Qigong, etc.), it may be necessary to accept RCTs 
without blinding of the patients or practitioners as the best possible evidence that can be obtained. 
However, it should be noted that this is also the case in trials of many conventional cancer treatments, 
e.g., radio- and chemotherapy. Regardless of the validity of the proposed mechanisms, the evidence of 
effects on cancer-relevant physical health outcomes at level B is limited. 
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Taken together, documented effectiveness of CAM seems primarily to be found for issues related to 
self-reported effects. Questionnaire-based investigations suggest that patients may choose to use CAM 
for reasons other than cure or improvement of survival, and results from clinical trials suggest the 
possibility of reductions in self-reported nausea and pain after acupuncture, or increases in measures of 
quality-of-life after treatment with mistletoe. While documented physiological effects associated with 
the self-reported outcomes are rare (level C), the available findings suggest that finding evidence at 
level D and E is most likely for selected forms of CAM.  
Finally, results from qualitative studies indicate that CAM may be a useful tool for the creation of 
meaning in a life situation that involves considerable distress for many patients. While many of the 
available qualitative studies, due to methodological limitations such as lack of control groups, are 
unable to establish whether CAM is the cause for the creation of meaning reported by patients, their 
results nevertheless suggest the potential usefulness of CAM in the search for subjective experiences 
of meaning and existential relief for those patients who choose to use CAM.  
For future research on CAM for cancer we see a number of challenges that must be dealt with. The 
first is to create research designs that are able to include a range of assessment tools in the same study. 
Research could move one step forward by employing several approaches in one trial;  
i.e., simultaneous investigations of whether a given therapy has any impact on physiological measures, 
on self-reported measures, and/or with respect to establishing meaning or existential relief to the 
patient in a situation characterized by fear and uncertainty. Cross-disciplinary studies of different 
CAM modalities may provide a clearer picture of what CAM may and may not provide for cancer 
patients than the single-disciplinary studies available today. Furthermore, the issue of blinding has to 
be solved with respect to many forms of CAM—perhaps by renouncing on the common demand for 
double- or triple-blind trial designs. Finally, it may be necessary to renounce on the demand of 
randomization with regard to trials of CAM that involve personal involvement of the patients given 
that such forms of therapy may require a certain willingness to collaborate on behalf of the patients. 
This could be the case in therapies that are based on repeated physical exercises (e.g., qigong) or are 
contrary to everyday experiences (e.g., spiritual healing for persons living in secular societies). 
Regardless of whether randomization is involved or not, control groups of patients receiving sham 
treatment or treatment-as-usual are possible to establish and should be employed to distinguish 
between the effectiveness of the therapy of the trial and the natural development of disease and 
recovery. If it turns out that it is possible to provide documentation of effect at any of the proposed 
levels, it would be relevant to establish experiments that could shed light on the working mechanisms 
of the form of therapy involved.  
If used when designing and reporting results of individual studies as well as systematic reviews of 
the available evidence, the proposed taxonomy could provide the oncologist with a tool to assist cancer 
patients in making more well-informed choices concerning use of and expectations to CAM.  
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